Janet Sasso

Information Scientist/CAS

Bio

Janet M. Sasso earned her B.S. in Biology from The Ohio State University. She also holds her Master of Public Health from OSU where she focused her research on public health equity and education. She joined CAS in 2006 as an Information Scientist in the life sciences department curating pharmacology, pharmaceutical, environmental science, and toxicological research information. She and her team have recently studied the landscape of the gut-brain alliance in respect to mental and gastrointestinal health and disorders.

Emerging Science
Stay ahead of the curve with insights from experts! Join our webinar featuring Lawrence Livermore National Lab, Oak Ridge National Lab, The Ohio State University, and CAS. Discover trends like AI’s impact in R&D, biomaterials, and tackling the undruggable.
February 15, 2024|Webinar
Biotechnology
Learn how biomarkers can improve cancer detection and treatment outcomes, and discover the latest research on pancreatic and liver cancer biomarkers. Read more.
February 9, 2024|Article
Emerging Science
Learn how cancer biomarkers can help detect and treat cancer early. Read this report by CAS and Excelra to discover the latest advances and trends.
February 9, 2024|Insights Report
Drug Discovery
Learn how antibody-drug conjugates (ADCs) are transforming cancer treatment with their targeted and potent action. Discover the latest trends and developments in ADC research and development.
October 12, 2023|Article
Emerging Science
Explore the fascinating connection between the gut microbiome and the brain in this webinar featuring experts from CAS, Bayer, and Caltech. Learn how the gut-brain axis influences health from IBS to autism and how microbiome manipulation can offer new therapeutic strategies.
September 22, 2023|Webinar
Biotechnology
Discover how exosomes, nature's lipid nanoparticles, are reshaping drug delivery and treatment of diseases from cancer to cardiovascular disease and beyond. Learn from experts at Mayo Clinic, Direct Biologics, and Aruna Bio in our recent ACS webinar. Watch the recording and read the full Insight Report now.
March 15, 2023|Webinar
Drug Discovery
Landscape view of emerging contributors, companies, and researchers in the emerging field of exosome research. This article overviews key players in diagnostics and therapeutic fields of exosome research with a deeper look into the current clinical pipeline.
December 15, 2022|Article
Drug Discovery
Learn more about the expert panel discussion on molecular glues and targeted protein degradation. Expert panelists include Dr. Benjamin Ebert, the chair of Medical Oncology at the Dana-Farber Institute, Dr. Phil Chamberlain, the co-founder, President, and CEO of Neomorph, and Janet Sasso, an information scientist specializing in Life Sciences at CAS.
October 12, 2022|Webinar
Digital R&D
"When you’re finished changing, you’re finished." Business leaders likely weren't the intended audience when Benjamin Franklin uttered his now famous quote. However, his words likely resonate deeply with leaders in today's rapidly evolving marketplace who know that for their business to thrive, they must be prepared to adapt and embrace new technologies.
September 26, 2022|Article
Drug Discovery
As COVID-19 cases rise again worldwide, the Omicron subvariant BA.5 is currently the dominant strain. This blog explores some key mutations that increase transmission, evade protective antibodies, and increase the rate of (re)infection.
July 20, 2022|Article
Biotechnology
Molecular glues have been used to uncover new therapeutic agents. Because of their targeted protein degradation that holds them together, these glues have exciting potential in uncovering new drugs to fight cancer, immune diseases, and more.
June 21, 2022|Article
Emerging Science
With recent headlines on monkeypox, learn more about the research landscape, scientific profiles, and currently available therapies. A deeper understanding of the published science enables clarity and insight on this emerging news story.
May 31, 2022|Article
Biotechnology
We are in the midst of a therapeutic revolution, according to the authors of a recent review article in Frontiers in Bioengineering and Biotechnology. They were commenting on the rapid expansion of RNA therapeutics in modern research and clinical development, driven in part by interest in RNA COVID-19 vaccines in the ongoing SARS-CoV-2 pandemic.
May 6, 2022|Article
Biotechnology
With recent mRNA booster recommendations, many ask if they should get a COVID-19 booster and what the science shows? This blog explains the science of boosters, reviews current recommendations, and examines recent research.
September 23, 2021|Article